Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms
Detection Principle
ImmunoAssay-Antigen
Testing Method Category
Testing Method
kit
Testing Method - Additional Info
Panbio™ COVID-19 AG Rapid Test Device
Reported Performance
sensitivity: 73.3% (overall), 86.5% (<7 dpo), 53.8% (>7 dpo); Specificity: 100%
Sample Size
255 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements